{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:13:58Z","timestamp":1789236838472,"version":"build-2803163510"},"reference-count":193,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of heart problems stemming from a compromised coronary blood supply to the myocardium. The severity of the disease ranges from an unstable manifestation of ischemic symptoms, such as unstable angina, to myocardial death, that is, the immediate life-threatening condition of myocardial infarction. Even though patients may survive myocardial infarction, the resulting ischemia-reperfusion injury triggers a cascade of inflammatory reactions and oxidative stress that poses a significant threat to myocardial function following successful revascularization. Moreover, despite evidence suggesting the presence of cardiac stem cells, the fact that cardiomyocytes are terminally differentiated and cannot significantly regenerate after injury accounts for the subsequent progression to ischemic cardiomyopathy and ischemic heart failure, despite the current advancements in cardiac medicine. In the last two decades, researchers have realized the possibility of utilizing stem cell plasticity for therapeutic purposes. Indeed, stem cells of different origin, such as bone-marrow- and adipose-derived mesenchymal stem cells, circulation-derived progenitor cells, and induced pluripotent stem cells, have all been shown to play therapeutic roles in ischemic heart disease. In addition, the discovery of stem-cell-associated paracrine effects has triggered intense investigations into the actions of exosomes. Notwithstanding the seemingly promising outcomes from both experimental and clinical studies regarding the therapeutic use of stem cells against ischemic heart disease, positive results from fraud or false data interpretation need to be taken into consideration. The current review is aimed at overviewing the therapeutic application of stem cells in different categories of ischemic heart disease, including relevant experimental and clinical outcomes, as well as the proposed mechanisms underpinning such observations.<\/jats:p>","DOI":"10.3390\/ijms25073778","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:52:12Z","timestamp":1711630332000},"page":"3778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Stem Cell Therapy against Ischemic Heart Disease"],"prefix":"10.3390","volume":"25","author":[{"given":"I-Ting","family":"Tsai","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung City 82445, Taiwan"},{"name":"School of Medicine, College of Medicine, I-Shou University, Kaohsiung City 82445, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2524-9684","authenticated-orcid":false,"given":"Cheuk-Kwan","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, I-Shou University, Kaohsiung City 82445, Taiwan"},{"name":"Department of Emergency Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung City 80794, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","article-title":"Acute coronary syndromes","volume":"399","author":"Bergmark","year":"2022","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204\u20131222."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12968-023-00958-5","article-title":"ACC\/AHA\/ASE\/ASNC\/ASPC\/HFSA\/HRS\/SCAI\/SCCT\/SCMR\/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease","volume":"25","author":"Winchester","year":"2023","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute Myocardial Infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_6","first-page":"608","article-title":"Mesenchymal Stem Cell Therapy for Patients with Ischemic Heart Failure- Past, Present, and Future","volume":"16","author":"Liang","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1590\/S0066-782X2002000400006","article-title":"Acute myocardial infarction: The first manifestation of ischemic heart disease and relation to risk factors","volume":"78","author":"Manfroi","year":"2002","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(19)32972-1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: Updated 5-year outcomes from the randomised, non-inferiority NOBLE trial","volume":"395","author":"Holm","year":"2020","journal-title":"Lancet"},{"key":"ref_9","first-page":"819","article-title":"Medical management of stable coronary artery disease","volume":"83","author":"Pflieger","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/eurjpc\/zwab213","article-title":"Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990\u20132019","volume":"29","author":"Safiri","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00109-003-0432-0","article-title":"New directions in strategies using cell therapy for heart disease","volume":"81","author":"Itescu","year":"2003","journal-title":"J. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.83.1.1","article-title":"Ventricular myocytes are not terminally differentiated in the adult mammalian heart","volume":"83","author":"Anversa","year":"1998","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilization of endothelial progenitor cells in patients with acute myocardial infarction","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.gendis.2023.01.031","article-title":"Cardiac regeneration: Pre-existing cardiomyocyte as the hub of novel signaling pathway","volume":"11","author":"Wang","year":"2024","journal-title":"Genes. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13287-017-0697-9","article-title":"A brief review: The therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction","volume":"8","author":"Miao","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/CIRCULATIONAHA.119.042351","article-title":"Endothelial Progenitor Cells Do Not Originate From the Bone Marrow","volume":"140","author":"Fujisawa","year":"2019","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/jcp.31060","article-title":"The origin, progress, and application of cell-based cardiac regeneration therapy","volume":"238","author":"Zhuo","year":"2023","journal-title":"J. Cell Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/01.RES.0000046045.00846.B0","article-title":"Stem cells for myocardial regeneration","volume":"91","author":"Orlic","year":"2002","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1071-3581(03)00580-4","article-title":"Stem cells and cardiovascular disease","volume":"10","author":"Abbott","year":"2003","journal-title":"J. Nucl. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2003.08.002","article-title":"Stem cell therapy for ischemic heart disease","volume":"9","author":"Hassink","year":"2003","journal-title":"Trends Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1527-5299.2002.00292.x","article-title":"Cellular cardiomyoplasty\u2014A novel approach to treat heart disease","volume":"8","author":"Kedes","year":"2002","journal-title":"Congest. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.1159","article-title":"Cardiac stem cells","volume":"197","author":"Hughes","year":"2002","journal-title":"J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00059-002-2427-y","article-title":"Endothelial progenitor cells: Regulation and contribution to adult neovascularization","volume":"27","author":"Walter","year":"2002","journal-title":"Herz"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-8-88","article-title":"Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy","volume":"8","author":"Lin","year":"2010","journal-title":"J. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1479-5876-9-11","article-title":"Myocardium-derived conditioned medium improves left ventricular function in rodent acute myocardial infarction","volume":"9","author":"Leu","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2010.03.007","article-title":"Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: An echocardiographic, six-month angiographic, and molecular-cellular study","volume":"150","author":"Leu","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1536\/ihj.14-007","article-title":"Prompt bone marrow-derived mesenchymal stem cell therapy enables early porcine heart function recovery from acute myocardial infarction","volume":"55","author":"Fan","year":"2014","journal-title":"Int. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.044","article-title":"Combined therapy with shock wave and autologous bone marrow-derived mesenchymal stem cells alleviates left ventricular dysfunction and remodeling through inhibiting inflammatory stimuli, oxidative stress & enhancing angiogenesis in a swine myocardial infarction model","volume":"193","author":"Sheu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41536-017-0024-1","article-title":"Translational cardiac stem cell therapy: Advancing from first-generation to next-generation cell types","volume":"2","author":"Cambria","year":"2017","journal-title":"NPJ Regen. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1208227","DOI":"10.3389\/fcvm.2023.1208227","article-title":"Research trends in cardiovascular tissue engineering from 1992 to 2022: A bibliometric analysis","volume":"10","author":"Lai","year":"2023","journal-title":"Front Cardiovasc. Med."},{"key":"ref_32","unstructured":"(2023, November 20). Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehad720","article-title":"Platelet biology and function: Plaque erosion vs. rupture","volume":"45","author":"Baaten","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_34","first-page":"2524","article-title":"Cardiovascular mortality in patients with acute and chronic coronary syndrome: Insights from the clinical evidence on ticagrelor","volume":"26","author":"Gargiulo","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_35","first-page":"376","article-title":"Stable Coronary Artery Disease: Treatment","volume":"97","author":"Braun","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/heartjnl-2022-321870","article-title":"Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome","volume":"109","author":"Cartlidge","year":"2023","journal-title":"Heart"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacasi.2022.10.013","article-title":"Diagnostic and Therapeutic Strategies for Stable Coronary Artery Disease following the ISCHEMIA Trial","volume":"3","author":"Kohsaka","year":"2023","journal-title":"JACC Asia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCULATIONAHA.123.065300","article-title":"Arrhythmia and Death following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses from the REVIVED-BCIS2 Trial","volume":"148","author":"Perera","year":"2023","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.hco.0000179821.11071.79","article-title":"The clinical significance of endothelial dysfunction","volume":"20","author":"Landmesser","year":"2005","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_40","first-page":"229","article-title":"Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes","volume":"43","author":"Wojakowski","year":"2005","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/hrt.2006.103358","article-title":"Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: Relevant reparatory mechanism?","volume":"94","author":"Wojakowski","year":"2008","journal-title":"Heart"},{"key":"ref_42","first-page":"57","article-title":"Hematopoietic stem cells: Ex-vivo expansion and therapeutic potential for myocardial ischemia","volume":"3","author":"Lu","year":"2010","journal-title":"Stem Cells Cloning"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.RES.0000185811.71306.8b","article-title":"Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: First randomized and placebo-controlled study","volume":"97","author":"Erbs","year":"2005","journal-title":"Circ. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.carrev.2018.05.018","article-title":"Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials","volume":"20","author":"Velagapudi","year":"2019","journal-title":"Cardiovasc. Revascularization Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13287-020-01835-z","article-title":"Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy","volume":"11","author":"Sung","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1074248407303139","article-title":"Therapeutic angiogenesis with bone marrow\u2014Derived stem cells","volume":"12","author":"Tse","year":"2007","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1525-1594.2004.07320.x","article-title":"Cultured autologous human cells for hard tissue regeneration: Preparation and characterization of mesenchymal stem cells from bone marrow","volume":"28","author":"Kotobuki","year":"2004","journal-title":"Artif. Organs"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2009.685","article-title":"Intramyocardial bone marrow cell injection for chronic myocardial ischemia: A randomized controlled trial","volume":"301","author":"Bax","year":"2009","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","article-title":"Intracoronary Transfusion of Circulation-Derived CD34+ Cells Improves Left Ventricular Function in Patients with End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention","volume":"43","author":"Lee","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sung, P.H., Li, Y.C., Lee, M.S., Hsiao, H.Y., Ma, M.C., Pei, S.N., Chiang, H.J., Lee, F.Y., and Yip, H.K. (2020). Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041043"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights from Randomized Controlled Trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Soetisna, T.W., Thamrin, A.M.H., Permadijana, D., Ramadhani, A.N.E., Santoso, A., and Mansyur, M. (2023). Intramyocardial Stem Cell Transplantation during Coronary Artery Bypass Surgery Safely Improves Cardiac Function: Meta-Analysis of 20 Randomized Clinical Trials. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134430"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCRESAHA.115.308165","article-title":"PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients with Left Ventricular Dysfunction Post STEMI","volume":"120","author":"Quyyumi","year":"2017","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and Treatment of Acute Coronary Syndromes: A Review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle-, and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: Quantifying the epidemiological transition","volume":"386","author":"Murray","year":"2015","journal-title":"Lancet"},{"key":"ref_58","first-page":"544","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"74","author":"Collet","year":"2021","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jcin.2020.04.004","article-title":"Clinical Characteristics and Outcomes of STEMI Patients with Cardiogenic Shock and Cardiac Arrest","volume":"13","author":"Omer","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jjcc.2021.10.030","article-title":"Stem cell therapy for acute myocardial infarction\u2014Focusing on the comparison between Muse cells and mesenchymal stem cells","volume":"80","author":"Yamada","year":"2022","journal-title":"J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1253\/circj.72.1336","article-title":"Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction","volume":"72","author":"Yip","year":"2008","journal-title":"Circ. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-017-0585-3","article-title":"A brief review: Adipose-derived stem cells and their therapeutic potential in cardiovascular diseases","volume":"8","author":"Ma","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.recesp.2015.02.025","article-title":"Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease","volume":"68","author":"Badimon","year":"2015","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_64","first-page":"389","article-title":"Therapeutic application of adipose derived stem cells in acute myocardial infarction: Lessons from animal models","volume":"10","author":"Naaijkens","year":"2014","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12265-014-9585-1","article-title":"Application of adipose-derived stem cells in heart disease","volume":"7","author":"Chen","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/RLI.0b013e318214a63f","article-title":"Immediate intramyocardial bone marrow-derived mononuclear cells implantation in minipig myocardium after permanent coronary artery ligation: Magnetic resonance imaging with histopathologic and immunochemical correlation","volume":"46","author":"Ko","year":"2011","journal-title":"Investig. Radiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4252\/wjsc.v11.i10.831","article-title":"Unmodified autologous stem cells at point of care for chronic myocardial infarction","volume":"11","author":"Haenel","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1333732","DOI":"10.3389\/fcvm.2023.1333732","article-title":"Editorial: [Application of stem cells in the treatment of myocardial infarction]","volume":"10","author":"Sun","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40256-023-00614-4","article-title":"Cardioprotective Strategies After Ischemia-Reperfusion Injury","volume":"24","author":"Zhang","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00009.2023","article-title":"Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: A matter of timing","volume":"104","author":"Vincent","year":"2024","journal-title":"Physiol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4614-4118-2_14","article-title":"Complement system activation in cardiac and skeletal muscle pathology: Friend or foe?","volume":"735","author":"Syriga","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2023.11.013","article-title":"Metal profiling in coronary ischemia-reperfusion injury: Implications for KEAP1\/NRF2 regulated redox signaling","volume":"210","author":"Yang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-5273(02)00189-4","article-title":"Oxidative stress and neutrophil activation\u2014The two keystones of ischemia\/reperfusion injury","volume":"86","author":"Kaminski","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12265-023-10401-w","article-title":"Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives","volume":"16","author":"Chang","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., and Takahashi, K. (2021). Treatment of Oxidative Stress with Exosomes in Myocardial Ischemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041729"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3000605231202573","DOI":"10.1177\/03000605231202573","article-title":"Mechanism of heart failure after myocardial infarction","volume":"51","author":"Jiang","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yjmcc.2023.10.003","article-title":"CaMKII, \u2018jack of all trades\u2019 in inflammation during cardiac ischemia\/reperfusion injury","volume":"184","author":"Zhang","year":"2023","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Luo, Y., Peng, L., Rong, X., Liu, Y., Li, J., and Luo, J. (2023). Ferroptosis in cardiovascular diseases: Role and mechanism. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-01169-2"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e027862","DOI":"10.1161\/JAHA.122.027862","article-title":"Scavenger Receptors in Myocardial Infarction and Ischemia\/Reperfusion Injury: The Potential for Disease Evaluation and Therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"101884","DOI":"10.1016\/j.arr.2023.101884","article-title":"Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia\/reperfusion injury","volume":"86","author":"Yang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2298514","DOI":"10.1080\/10717544.2023.2298514","article-title":"Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: Current strategies and future prospective","volume":"31","author":"Li","year":"2024","journal-title":"Drug Deliv."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ko, S.F., Sung, P.H., Yang, C.C., Chiang, J.Y., and Yip, H.K. (2023). Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury. Biomed. J., 46.","DOI":"10.1016\/j.bj.2022.06.002"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOT.0b013e32835c2a05","article-title":"Ischemia-reperfusion injury: Beneficial effects of mesenchymal stromal cells","volume":"18","author":"Souidi","year":"2013","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_84","first-page":"5375","article-title":"Early administration of cold water and adipose derived mesenchymal stem cell derived exosome effectively protects the heart from ischemia-reperfusion injury","volume":"11","author":"Chai","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1007\/s11033-021-06359-0","article-title":"Modulation of autophagy as the target of mesenchymal stem cells-derived conditioned medium in rat model of myocardial ischemia\/reperfusion injury","volume":"48","author":"Mokhtari","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"La Mantia, D., Bernardini, C., Zannoni, A., Salaroli, R., Wang, C., Bencivenni, S., and Forni, M. (2022). Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis. Animals, 12.","DOI":"10.3390\/ani12060749"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1182209","DOI":"10.3389\/fcvm.2023.1182209","article-title":"Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: First three case reports","volume":"10","author":"Kawamura","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.118.313568","article-title":"Medical Therapy for Heart Failure Caused by Ischemic Heart Disease","volume":"124","author":"Elgendy","year":"2019","journal-title":"Circ. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u2018malignant\u2019 than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur. J. Heart Fail."},{"key":"ref_90","first-page":"e46486","article-title":"Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies","volume":"15","author":"Sapna","year":"2023","journal-title":"Cureus"},{"key":"ref_91","first-page":"339","article-title":"Stem celltherapy for ischemic heart failure","volume":"32","author":"Rosenstrauch","year":"2005","journal-title":"Tex. Heart Inst. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.CIR.0000070596.30552.8B","article-title":"Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure","volume":"107","author":"Perin","year":"2003","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12471-018-1213-2","article-title":"Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia","volume":"27","author":"Mann","year":"2019","journal-title":"Neth. Heart J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e027727","DOI":"10.1161\/JAHA.122.027727","article-title":"Heart Failure Impairs Bone Marrow Hematopoietic Stem Cell Function and Responses to Injury","volume":"12","author":"Marvasti","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7471582","DOI":"10.1155\/2017\/7471582","article-title":"Cardiac Progenitor Cells and the Interplay with Their Microenvironment","volume":"2017","author":"Mauretti","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphys.2015.00123","article-title":"Multipotent stem cells of the heart-do they have therapeutic promise?","volume":"6","author":"Leite","year":"2015","journal-title":"Front. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ar.20858","article-title":"Cardiac stem cell research: An elephant in the room?","volume":"292","author":"Colorito","year":"2009","journal-title":"Anat. Rec."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.118.311208","article-title":"New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications","volume":"123","author":"Vagnozzi","year":"2018","journal-title":"Circ. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.116.309710","article-title":"The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin\u2019 Away","volume":"120","author":"Cai","year":"2017","journal-title":"Circ. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldr018","article-title":"Cardiac cell therapy: Where we\u2019ve been, where we are, and where we should be headed","volume":"98","author":"Malliaras","year":"2011","journal-title":"Br. Med. Bull."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13287-016-0415-z","article-title":"Discrepancy between short-term and long-term effects of bone marrow-derived cell therapy in acute myocardial infarction: A systematic review and meta-analysis","volume":"7","author":"Lee","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1153428","DOI":"10.3389\/fcvm.2023.1153428","article-title":"Safety and efficacy of intracoronary artery administration of human bone marrow-derived mesenchymal stem cells in STEMI of Lee-Sung pigs-A preclinical study for supporting the feasibility of the OmniMSC-AMI phase I clinical trial","volume":"10","author":"Chen","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_103","first-page":"187","article-title":"Amniotic Membrane-Derived Mesenchymal Stem Cells for Heart Failure: A Systematic Review and Meta-Analysis of the Published Preclinical Studies","volume":"35","author":"Gorjipour","year":"2021","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","article-title":"Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: Systematic review and meta-analysis of large animal studies","volume":"116","author":"Eding","year":"2015","journal-title":"Circ. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cellbi.2009.08.008","article-title":"Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts","volume":"33","author":"Gai","year":"2009","journal-title":"Cell Biol. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000227815","article-title":"Cardiac myocytes derived from murine reprogrammed fibroblasts: Intact hormonal regulation, cardiac ion channel expression and development of contractility","volume":"24","author":"Pfannkuche","year":"2009","journal-title":"Cell Physiol. Biochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1261330","DOI":"10.3389\/fcvm.2023.1261330","article-title":"In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging","volume":"10","author":"Saito","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_108","first-page":"67","article-title":"Therapeutic effects of adipose derived fresh stromal vascular fraction-containing stem cells versus cultured adipose derived mesenchymal stem cells on rescuing heart function in rat after acute myocardial infarction","volume":"11","author":"Sheu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11748-021-01696-0","article-title":"Modifying strategies for SDF-1\/CXCR4 interaction during mesenchymal stem cell transplantation","volume":"70","author":"Jiang","year":"2022","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"682342","DOI":"10.3389\/fcvm.2021.682342","article-title":"A Brief History in Cardiac Regeneration, and How the Extra Cellular Matrix May Turn the Tide","volume":"8","author":"Bouten","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: Why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell-cell communication by extracellular vesicles","volume":"23","author":"Carter","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","article-title":"Biogenesis of extracellular vesicles (EV): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies","volume":"113","author":"Akers","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Oncel","year":"2022","journal-title":"J. Control Release"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zou, Y., Song, C., Cao, K., Cai, K., Chen, S., Wu, Y., Geng, D., Sun, G., and Zhang, N. (2023). Advances in the Study of Exosomes in cardiovascular diseases. J. Adv. Res., in press.","DOI":"10.1016\/j.jare.2023.12.014"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/10409238.2010.502516","article-title":"The ESCRT complexes","volume":"45","author":"Hurley","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Krylova, S.V., and Feng, D. (2023). The Machinery of Exosomes: Biogenesis, Release, and Uptake. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021337"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","article-title":"The ESCRT machinery","volume":"22","author":"Schmidt","year":"2012","journal-title":"Curr. Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.devcel.2011.05.015","article-title":"The ESCRT pathway","volume":"21","author":"Henne","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ceb.2007.12.002","article-title":"ESCRT complexes and the biogenesis of multivesicular bodies","volume":"20","author":"Hurley","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Larios, J., Mercier, V., Roux, A., and Gruenberg, J. (2020). ALIX- and ESCRT-III-dependent sorting of tetraspanins to exosomes. J. Cell Biol., 219.","DOI":"10.1083\/jcb.201904113"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.1155750","article-title":"Cell biology. No ESCRTs for exosomes","volume":"319","author":"Marsh","year":"2008","journal-title":"Science"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Jankovicova, J., Secova, P., Michalkova, K., and Antalikova, J. (2020). Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207568"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","article-title":"Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation","volume":"4","author":"Yang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"659621","DOI":"10.3389\/fimmu.2021.659621","article-title":"The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Tan, T.T., Lai, R.C., Padmanabhan, J., Sim, W.K., Choo, A.B.H., and Lim, S.K. (2021). Assessment of Tumorigenic Potential in Mesenchymal-Stem\/Stromal-Cell-Derived Small Extracellular Vesicles (MSC-sEV). Pharmaceuticals, 14.","DOI":"10.3390\/ph14040345"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-020-02622-3","article-title":"Mesenchymal stem cell derived-exosomes: A modern approach in translational medicine","volume":"18","author":"Nikfarjam","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.1074\/jbc.RA119.007537","article-title":"Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction","volume":"294","author":"Eguchi","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/15384101.2019.1711305","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomes transfers microRNA-19a to protect cardiomyocytes from acute myocardial infarction by targeting SOX6","volume":"19","author":"Huang","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Suh, J.H., Joo, H.S., Hong, E.B., Lee, H.J., and Lee, J.M. (2021). Therapeutic Application of Exosomes in Inflammatory Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031144"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11626-020-00481-2","article-title":"Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling","volume":"56","author":"Chen","year":"2020","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","article-title":"HIF-1alpha overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijcard.2014.03.015","article-title":"Direct implantation versus platelet-rich fibrin-embedded adipose-derived mesenchymal stem cells in treating rat acute myocardial infarction","volume":"173","author":"Sun","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12265-022-10216-1","article-title":"Modified Exosomes: A Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease","volume":"15","author":"Chen","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/hdy.2015.84","article-title":"Microguards and micromessengers of the genome","volume":"116","author":"Green","year":"2016","journal-title":"Heredity"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"bau103","DOI":"10.1093\/database\/bau103","article-title":"VIRmiRNA: A comprehensive resource for experimentally validated viral miRNAs and their targets","volume":"2014","author":"Qureshi","year":"2014","journal-title":"Database"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Pan, Y., Wu, W., Jiang, X., and Liu, Y. (2023). Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy. Biomed. Pharmacother., 163.","DOI":"10.1016\/j.biopha.2023.114817"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3892\/ijmm.2021.5041","article-title":"Knockdown of mesenchymal stem cell-derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARgamma\/LXRalpha\/ABCA1 signaling pathway","volume":"48","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/abbs\/gmab102","article-title":"Mesenchymal stem cell-derived exosomal miR-21a-5p promotes M2 macrophage polarization and reduces macrophage infiltration to attenuate atherosclerosis","volume":"53","author":"Ma","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"119249","DOI":"10.1016\/j.lfs.2021.119249","article-title":"Mouse bone marrow derived mesenchymal stem cells-secreted exosomal microRNA-125b-5p suppresses atherosclerotic plaque formation via inhibiting Map4k4","volume":"274","author":"Lin","year":"2021","journal-title":"Life Sci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.18632\/aging.102857","article-title":"Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against atherosclerosis","volume":"12","author":"Xing","year":"2020","journal-title":"Aging"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.omtn.2020.10.037","article-title":"Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A","volume":"23","author":"Yang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41419-020-02783-5","article-title":"Long noncoding RNA UCA1 from hypoxia-conditioned hMSC-derived exosomes: A novel molecular target for cardioprotection through miR-873-5p\/XIAP axis","volume":"11","author":"Sun","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13287-022-02969-y","article-title":"Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1\/NF-kappaB p65 pathway","volume":"13","author":"Xiong","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.7150\/thno.28021","article-title":"Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction","volume":"8","author":"Zhu","year":"2018","journal-title":"Theranostics"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13287-019-1522-4","article-title":"LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p\/Sirt1 axis","volume":"10","author":"Mao","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.118.312758","article-title":"Transplanted Mesenchymal Stem Cells Reduce Autophagic Flux in Infarcted Hearts via the Exosomal Transfer of miR-125b","volume":"123","author":"Xiao","year":"2018","journal-title":"Circ. Res."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zheng, H., Liang, X., Han, Q., Shao, Z., Zhang, Y., Shi, L., Hong, Y., Li, W., Mai, C., and Mo, Q. (2021). Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence. J. Nanobiotechnol., 19.","DOI":"10.1186\/s12951-021-01077-y"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvz139","article-title":"Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19","volume":"116","author":"Huang","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-020-02091-x","article-title":"Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B\/BMP2\/BMF axis","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"119742","DOI":"10.1016\/j.lfs.2021.119742","article-title":"Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy","volume":"280","author":"Chen","year":"2021","journal-title":"Life Sci."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Lai, T.C., Lee, T.L., Chang, Y.C., Chen, Y.C., Lin, S.R., Lin, S.W., Pu, C.M., Tsai, J.S., and Chen, Y.L. (2020). MicroRNA-221\/222 Mediates ADSC-Exosome-Induced Cardioprotection Against Ischemia\/Reperfusion by Targeting PUMA and ETS-1. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.569150"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41420-022-00909-6","article-title":"Mesenchymal stem cell-derived exosomal microRNA-182-5p alleviates myocardial ischemia\/reperfusion injury by targeting GSDMD in mice","volume":"8","author":"Yue","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.ymthe.2020.06.026","article-title":"Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice","volume":"28","author":"Nakamura","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_162","first-page":"4007","article-title":"Exosomes released from mesenchymal stem cells overexpressing microRNA-30e ameliorate heart failure in rats with myocardial infarction","volume":"13","author":"Pu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/cbin.11664","article-title":"Exosomal microRNA-1246 from human umbilical cord mesenchymal stem cells potentiates myocardial angiogenesis in chronic heart failure","volume":"45","author":"Wang","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Meng, W.T., and Guo, H.D. (2023). Small Extracellular Vesicles Derived from Induced Pluripotent Stem Cells in the Treatment of Myocardial Injury. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054577"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/CIRCRESAHA.112.300625","article-title":"Direct cardiac reprogramming: From developmental biology to cardiac regeneration","volume":"113","author":"Qian","year":"2013","journal-title":"Circ. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.109.865154","article-title":"Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells","volume":"120","author":"Nelson","year":"2009","journal-title":"Circulation"},{"key":"ref_168","first-page":"365","article-title":"Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease","volume":"30","author":"Chao","year":"2014","journal-title":"Acta Cardiol. Sin."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Rosales, R.M., Mountris, K.A., Olivan-Viguera, A., Perez-Zabalza, M., Cedillo-Servin, G., Iglesias-Garcia, O., Hrynevich, A., Castilho, M., Malda, J., and Prosper, F. (2024). Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction. Comput. Biol. Med., 171.","DOI":"10.1016\/j.compbiomed.2024.108044"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/hmg\/ddad165","article-title":"Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes","volume":"33","author":"Park","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41598-024-52871-1","article-title":"Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues","volume":"14","author":"Maurissen","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcp.31161","article-title":"Cadherin-5 facilitated the differentiation of human induced pluripotent stem cells into sinoatrial node-like pacemaker cells by regulating beta-catenin","volume":"239","author":"Zhang","year":"2024","journal-title":"J. Cell Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Vo, Q.D., Saito, Y., Nakamura, K., Iida, T., and Yuasa, S. (2024). Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020987"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1007\/s12010-023-04446-5","article-title":"Combined Application of Human Amniotic Membrane Mesenchymal Stem Cells and a Modified PGS-co-PCL Film in an Experimental Model of Myocardial Ischemia-Reperfusion Injury","volume":"195","author":"Bahrami","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13287-023-03322-7","article-title":"Engineering of MSCs sheet for the prevention of myocardial ischemia and for left ventricle remodeling","volume":"14","author":"Chang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2004.12.006","article-title":"Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease","volume":"100","author":"Wang","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"ref_177","first-page":"CD008844","article-title":"Granulocyte colony stimulating factor therapy for acute myocardial infarction","volume":"2013","author":"Moazzami","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH15-07-0589","article-title":"Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial","volume":"115","author":"Steppich","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Leone, A.M., D\u2019Amario, D., Cannata, F., Graziani, F., Borovac, J.A., Leone, G., De Stefano, V., Basile, E., Siracusano, A., and Galiuto, L. (2020). The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041214"},{"key":"ref_180","first-page":"2975","article-title":"Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients\u2014A phase I clinical trial to evaluate safety and tolerability","volume":"10","author":"Sung","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jss.2010.05.057","article-title":"Optimizing stem cell function for the treatment of ischemic heart disease","volume":"166","author":"Herrmann","year":"2011","journal-title":"J. Surg. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10741-016-9576-1","article-title":"New strategies for improving stem cell therapy in ischemic heart disease","volume":"21","author":"Huang","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijcard.2014.07.071","article-title":"Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: The role of the RhoA\/ROCK\/ERK pathway","volume":"176","author":"Zhang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Song, L., Yang, Y.J., Dong, Q.T., Qian, H.Y., Gao, R.L., Qiao, S.B., Shen, R., He, Z.X., Lu, M.J., and Zhao, S.H. (2013). Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065702"},{"key":"ref_185","first-page":"1058","article-title":"Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: Role of CXCR4","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_186","first-page":"259","article-title":"Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: A review","volume":"3","author":"Sun","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.avsg.2010.03.027","article-title":"Shock wave-pretreated bone marrow cells further improve left ventricular function after myocardial infarction in rabbits","volume":"24","author":"Sheu","year":"2010","journal-title":"Ann. Vasc. Surg."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-981-10-4397-0_18","article-title":"Therapeutic Effects of Ischemic-Preconditioned Exosomes in Cardiovascular Diseases","volume":"998","author":"Ding","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient regenerative potential of the neonatal mouse heart","volume":"331","author":"Porrello","year":"2011","journal-title":"Science"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCRESAHA.115.307017","article-title":"Functional Recovery of a Human Neonatal Heart after Severe Myocardial Infarction","volume":"118","author":"Haubner","year":"2016","journal-title":"Circ. Res."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Zhang, S., Yang, Y., Lv, X., Liu, W., Zhu, S., Wang, Y., and Xu, H. (2023). Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115677"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"6500831","DOI":"10.1155\/2023\/6500831","article-title":"Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease","volume":"2023","author":"Yin","year":"2023","journal-title":"Stem Cells Int."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/15353702231151960","article-title":"Therapeutic potentials of stem cell-derived exosomes in cardiovascular diseases","volume":"248","author":"Mani","year":"2023","journal-title":"Exp. Biol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:20:05Z","timestamp":1760106005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":193,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ijms25073778"],"URL":"https:\/\/doi.org\/10.3390\/ijms25073778","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]}}}